Table 4.
The association between level of hepatoma‐derived growth factor and the types of pulmonary arterial hypertension (PAH)
| Logistic regression adjusted for age and sex | Unadjusted rank‐sum test | ||||
|---|---|---|---|---|---|
| Coefficient | 95% confidence interval | p Value | p Value (rank‐sum) | ||
| IPAH | −0.181 | −0.292 | −0.071 | 0.001 | 0.001 |
| FPAH | −0.15 | −0.421 | 0.121 | 0.277 | 0.631 |
| APAH | 0.227 | 0.116 | 0.337 | <0.0001 | <0.0001 |
| APAH‐CTD | 0.086 | −0.037 | 0.208 | 0.17 | 0.43 |
| APAH‐CHD | 0.187 | −0.043 | 0.416 | 0.111 | 0.27 |
| PoPH | 0.469 | 0.222 | 0.717 | <0.0001 | <0.0001 |
| APAH‐HIV | −0.102 | −0.476 | 0.273 | 0.595 | 0.854 |
| PAH‐DrugTox | −0.153 | −0.408 | 0.101 | 0.237 | 0.296 |
Note: Bold values denote statistical significance at the p < 0.05 level.
Abbreviations: APAH, PAH associated with other conditions; CHD, congenital heart disease; CI, cardiac index; CTD, connective tissue disease; FPAH, familial PAH; IPAH, idiopathic PAH; PoPH, portopulmonary hypertension.